Related Experiment Video
Updated: Aug 13, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy
Danilo Neglia1, Antonio L'Abbate
1Clinical PET Laboratory, CNR Institute of Clinical Physiology, Via G. Moruzzi 1, 56124 Pisa, Italy. dneglia@ifc.cnr.it
Insights
Coronary microvascular dysfunction is an early characteristic of dilated cardiomyopathy (DCM), driving disease progression and predicting poor outcomes. Targeting the coronary microcirculation may offer new therapeutic strategies for heart failure.
Area of Science:
- Cardiology
- Cardiovascular Research
- Translational Medicine
Background:
- Coronary microvascular abnormalities are increasingly recognized in cardiac diseases.
- Dilated cardiomyopathy (DCM) exhibits early coronary microvessel dysfunction.
- This dysfunction appears to cause, rather than result from, myocardial damage.
Purpose of the Study:
- To investigate the role of coronary microcirculatory dysfunction in the early stages of DCM.
- To explore the mechanisms underlying progressive cardiac deterioration in DCM.
- To assess the prognostic significance of coronary microcirculatory dysfunction in DCM.
Main Methods:
- The abstract does not specify the methods used.
- Studies cited demonstrate the presence and extent of coronary microcirculatory dysfunction.
- Prognostic relevance was assessed in patients with early-stage DCM.
Main Results:
- Coronary microcirculatory dysfunction is an early feature of DCM.
- It contributes to progressive contractile impairment, ventricular dilation, and heart failure.
- Microvascular dysfunction is an independent predictor of worse prognosis in early DCM.
Conclusions:
- Coronary microcirculation plays a key role in DCM pathogenesis.
- Myocardial hypoperfusion and ischemia at the microvascular level are likely involved mechanisms.
- The coronary microcirculation represents a potential therapeutic target for DCM and heart failure risk.
Abstract:
There is growing evidence of the presence and relevance of coronary microvascular abnormalities in many cardiac diseases. In particular, it has been recently shown that dilated cardiomyopathy (DCM) is characterized by dysfunction of the coronary microvessels since its very early onset. Coronary microcirculatory dysfunction is not an effect of myocardial damage but seems in turn to cause progressive contractile impairment, ventricular dilation and heart failure. The mechanisms of the progressive deterioration of cardiac function in DCM are largely unknown but both myocardial hypoperfusion and myocardial ischemia at the microvascular level are most probably involved. It has been demonstrated that the presence and the extent of coronary microcirculatory dysfunction in patients with early stage DCM is an independent and relevant predictor of worse prognosis. From these studies it is more and more evident that the coronary microcirculation is involved in the pathogenesis ofDCMand should be considered a new target of treatment in those cardiac diseases at risk to evolve towards heart failure.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
